Objective: Determine whether higher targeted oxygen levels are associated with reduced incidence of pulmonary hypertension (PH) and elevated pulmonary vascular resistance (PVR) in extremely premature infants. Median time to PH development was significantly shorter in the lower saturation group than in the higher saturation group (5 days vs 12 days; P = 0.02), as was time to development of elevated PVR (4 days vs 6 days; P < 0.001). Duration of PH (P = 0.12) and elevated PVR (P = 0.86) did not differ significantly between groups. Cumulative incidence of PH (P = 0.04) and elevated PVR (P = 0.01) at 36 weeks post-menstrual age was significantly lower in the high saturation group compared to the lower saturation group.
| INTRODUCTION
Babies born extremely preterm (less than 29 weeks gestation), have decreased pulmonary vascular and alveolar growth. [1] [2] [3] Dysmorphic growth and impaired function of the pulmonary vasculature can result in pulmonary hypertension (PH) 4, 5 which is associated with substantial cardio-pulmonary vascular disease and risk of death. 6, 7 Oxygen, a potent pulmonary arterial vasodilator, is routinely provided to premature infants to treat lung disease and may prevent development of PH. 8 Oxygen, however, is a therapy with its own toxicity, including generation of free radicals, for which risks and benefits must be balanced when considering its use in premature infants. 9 Concerns about retinopathy of prematurity (ROP), other comorbidities and infant mortality therefore prompted clinical trials to try to settle uncertainty with respect to optimal targets for oxygen therapy in infants, between 2005 and 2007. Five randomized controlled trials [10] [11] [12] compared lower (85-89%) and higher (91-95%) oxygen saturation targets in premature infants. Some studies found a higher incidence of ROP in the higher saturation group, although increased incidence of necrotizing enterocolitis and mortality were seen in the lower saturation group in some studies, prompting cessation of the studies. [10] [11] [12] [13] [14] Subsequently, oxygen saturation targets were increased to 91-95% in neonatal intensive care units, based on recommendations from meta-analyses of these data. 13, [15] [16] [17] [18] The optimal oxygen saturation for extremely low birth weight infants in the postnatal period to minimize morbidity remains unknown. 16, 17 In particular, evidence is lacking on the effect of oxygen saturation on development of PH and increased pulmonary vascular resistance (PVR).
Since PH is an important contributor to morbidity and mortality, a change in its incidence could be an important impetus to modify clinical care. As chronic hypoxia causes pulmonary vasoconstriction, 19 we hypothesized that in extremely preterm infants, higher oxygen saturation (90-95%), as compared to lower oxygen saturation (88-92%) would result in lower incidence of PH and increased PVR.
| MATERIALS AND METHODS

| Study population
This retrospective chart review included all infants born at <29 weeks gestation, cared for at two tertiary care centers (the Ottawa Hospital Infants with BPD were defined as those requiring oxygen at 36 weeks corrected gestational age 22 as they could be readily identified on retrospective chart review and since oxygen reduction tests were not routinely performed in the time period during which the study was conducted. order to assess pulmonary artery pressure (PAP), which is directly correlated with PH, this method heavily relies on TR jet, which is not always present in infants. 24 PAAT and RVET are not TR-dependent and can be measured in all infants' echocardiograms. 25 They were therefore selected to estimate PAP and PH. 26 Both PAAT and PAAT /RVET ratio are altered in patients with PH and could be early markers for PH. 27, 28 A computed PAAT /RVET ratio <0.31 was considered indicative of increased PVR, as in previous studies. [29] [30] [31] Time to development and resolution of PH and elevated PVR were also considered. This was defined as absence of meeting the criteria for PH and elevated PVR. Finally, associations of PH and increased PVR with co-morbid conditions were examined.
| Study design and measurements
Cumulative incidence of PH and elevated PVR at 36 weeks post menstrual age (PMA) were also assessed as a more consistent measure for all infants, since their gestational age (GA) at birth varied. Incidence of early PH, 6 presenting before or on day of life 7, was compared to late onset PH.
| Data analysis
A priori sample size estimation was based on the following considerations. The time period during which lower oxygen saturation was targeted was roughly 2.5 times as long as the period during which higher saturation was targeted. Fixing the proportion of infants according to these durations, a sample size of 210 infants (150 with lower saturation and 60 with higher saturation) was necessary to provide 83% power to detect a reduction in incidence of PH from 20% to 5%. were estimated using Kaplan-Meier estimator; differences between groups were compared using the log-rank test. Hazard ratios for the development of PH and elevated PVR between the two oxygen saturation groups were estimated using Cox proportional hazard regression. As a sensitivity check, a sub-analysis using the same outcomes was also conducted for a restricted time period of 8 months before and after the change in saturation target, with an intervening washout period of 10 weeks to account for adaptation to the change in clinical practice.
Two-sided P-values less than 0.05 and hazard ratios with 95%
confidence interval not including a value of one were considered statistically significant.
3 | RESULTS
| Baseline participant characteristics
Of the 265 charts screened, 13 (4.9%) were ineligible as no echocardiograms were performed. The study population included 252 individuals with a median gestational age of 26.7 weeks (IQR:
25.4,28.0). This consisted of 195 infants in the lower oxygen saturation group and 57 in the higher oxygen saturation group. There were no significant differences between saturation groups in neonatal baseline characteristics ( Table 1 ), suggesting that the types of infants admitted to the unit did not change over the time of this study.
Echocardiograms were performed significantly later in the higher saturation group (day of life four in the higher saturation group versus day of life three in the lower saturation group; P = 0.002). Infants in the lower saturation group had on average one additional echocardiogram performed before discharge, as compared to the higher saturation group (Table 1) . Additional analysis conditioning on single versus multiple echocardiograms determined, however, that there was no significant interaction on diagnosis of PH. FIGURE 1 Development of PH and elevated PVR by week of post-menstrual age. Cumulative incidence of PH or elevated PVR in low and high oxygen saturation target groups is shown with 95% confidence intervals. The P-value of the log-rank test between the two groups is also shown. The number of patients at risk in each group is reported in the table below each graph. Censored observations are marked with " + ". Figure 2 ). Median time to resolution of PH and elevated PVR was not significantly different between two groups (P = 0.12 and P = 0.86; Figure 3 ). There was no significant difference in incidence of PH with respect to early (PH ≤ 7 DOL = 43.8%) versus early persistent (PH ≤ 7 DOL and PH>7 DOL = 24.7%) versus late (PH > 7 DOL = 31.5%) timing of its development between the lower and higher saturation groups.
The sensitivity of a low PAAT/RVET ratio for PH was 67% (IQR 61%, 73%) and the specificity was 66% (IQR 60%, 72%). The positive predictive value of low PAAT/RVET for development of PH was 45% (IQR 39%, 51%), whereas the negative predictive value was 83% (78%, 87%).
| Sub-group analyses
To account for possible effect of the integration period for the new oxygen saturation level, a sensitivity analysis was performed, repeating the analyses restricting data to the time period of 8 months before and after the change in saturation target, with an intervening washout period of 10 weeks. The population included 92 infants (41 in the lower saturation group, 51 in the higher saturation group) with a median gestational age of 26.6 weeks (IQR: 25.0, 28.0). There were no significant demographic differences between the saturation groups' baseline characteristics (Table 2 ).
This sub-group of the study population had findings that were similar to those demonstrated when the complete study population was included with regards to incidence and development of PH (Figures 1-3 ). However, in contrast to the complete study group, the sub-group analysis did not show significant differences in cumulative incidence and development of PVR between saturation groups (Figures 1 and 2 ).
FIGURE 2
Development of PH and elevated PVR by days since birth. Cumulative incidence of PH or elevated PVR in low and high oxygen saturation target groups is shown with 95% confidence intervals. The P-value of the log-rank test between the groups is also shown. The number of patients at risk in each group is reported in the table below each graph. Censored observations are marked with " + ". A, Development of PH in complete study population. The risk of developing PH was 50% lower in the higher oxygen saturation group compared to the lower saturation group (HR = 0.50, 95%CI 0.26-0.95; P = 0.032). B, Development of PH in wash-out sub-group a study population. The risk of developing PH was 58% lower in the higher oxygen saturation group compared to the lower saturation group (HR = 0.42, 95%CI 0.19-0.89; P = 0.02). C, Development of elevated PVR in complete study population. The risk of developing elevated PVR was 45% lower in the higher oxygen saturation group compared to the lower saturation group (HR = 0.55, 95%CI 0.38-0.81; P = 0.002). D, Development of elevated PVR in wash-out sub-group a study population. There was no statistically significant difference in risk of developing elevated PVR between the two saturation groups (HR = 0.77, 95%CI 0.46-1.29; P = 0.33). a The sub-group is a smaller subset of patients pre-and post-oxygen target change that included an appropriate "wash-out" period" LALIBERTÉ ET AL.
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| Co-morbidities
Presence of BPD, PDA and pneumonia were significantly associated with both PH and elevated PVR (Table 3) . Additionally, presence of NEC and death were significantly associated with PH. Lower birth weight was significantly associated with PH (P = 0.004) and elevated PVR (P < 0.001). Smaller size for gestational age was significantly associated with elevated PVR (P = 0.004) but not with PH (P = 0.32).
Cox regression analysis did not show an interaction between SGA and diagnosis of PH (P = 0.39). Other common neonatal co-morbidities
were not significantly associated with PH or elevated PVR.
FIGURE 3
Time (days) to resolution of the first occurrence of PH and elevated PVR (PAAT/RVET ratio <0.31). Cumulative probability (%) of persistence of PH or elevated PVR in low and high oxygen saturation target groups is shown with 95% confidence intervals. The p-value of the log-rank test between the groups is also shown. The number of patients at risk in each group is reported in the table below each graph. Censored observations are marked with " + ". A, Resolution of PH in complete study population. There was no statistically significant difference in time to resolution of PH between the two saturation groups (P = 0.51). B, Resolution of PH in wash-out sub-group a study
population. There was no statistically significant difference in time to resolution of PH between the two saturation groups (P = 0.80). C, Resolution of elevated PVR in complete study population. There was no statistically significant difference in time to resolution of elevated PVR between the two saturation groups (P = 0.055). D, Resolution of elevated PVR in wash-out sub-group a study population. There was no statistically significant difference in time to resolution of elevated PVR between the two saturation groups (P = 0.15). a The sub-group is a smaller subset of patients pre-and post-oxygen target change that included an appropriate "wash-out" period" There was no significant difference between low saturation and high saturation groups in incidence of children requiring supplemental oxygen at hospital discharge (n = 18 (29.5%), n = 7 (46.7%), P = 0.23)). PH incidence was also not significantly different between low and high saturation groups among those needing supplemental oxygen at discharge (n = 8 (24.2%), n = 17 (39.5%), P = 0.22).
There were a total of 32 deaths in the study population due to:
NEC ( BPD was significantly associated with both PH and elevated PVR in our study. We hypothesize that this is due to underdevelopment of the pulmonary architecture in extremely preterm infants; decreased alveolar-capillary surface area affects gas exchange, contributing to development of BPD, while impaired growth of the pulmonary vasculature results in smaller diameter pulmonary vessels with higher resistance and pressure. 21 Chronic hypoxia further contributes to pulmonary vasoconstriction, which further promotes increased PVR and PH.
Time to resolution of PH and elevated PVR was not significantly different between groups, however it is difficult to determine "true resolution" in this setting, as our data may not account for infants who had late onset PH and never received a follow-up echocardiogram to demonstrate resolution. 
| Comorbidities and mortality
BPD, PDA, and pneumonia were significantly associated with both PH and elevated PVR, as previously reported. 6, 7, 32, 37, 38 Interestingly, unlike other studies which found that high oxygen saturations were associated with increased incidence of ROP, 11-13 this study did not find a significant difference in ROP between groups. This may be due to the small sample size or the fact that the oxygen saturation targets overlapped, and the small difference in oxygen saturations did not permit to distinguish this effect. Mortality in our study was significantly higher in infants with PH, as previously reported, 6, 7 but not in infants with elevated PVR, which may be due to elevated PVR being a milder condition in the spectrum of PH.
| Limitations
This study has several limitations. First, at the time of this study, changes in neonatal practices to target higher oxygen saturations were still recent and it is difficult to ascertain whether oxygen targets were adhered to 100% of the time. It would require extensive exploration of the data collected by the oxygen saturation monitors to determine whether oxygen targets were consistently achieved. However, a subgroup analysis showed that risk of developing PH was persistently lower in higher oxygen saturation group compared to lower saturation group even after accounting for the transition phase.
Second, there was an overlap of the oxygen targets during both time periods (lower was 88-92%, higher was 90-95%), which makes it more difficult to compare groups. Also, a relatively smaller number (N = 57) of infants with higher targeted oxygen saturations were studied. These factors may have resulted in less power to detect differences in study 
| CONCLUSION
These findings suggest that higher oxygen saturation (90-95%) was associated with 50% lower risk of development of PH or 45% lower risk of elevated PVR in extremely preterm infants compared to lower oxygen saturation (88-92%). Higher oxygen saturation also delayed onset of PH and elevated PVR. These results require validation in a larger prospective study, although this may be difficult to achieve given current clinical practice. Whether an elevated PVR predicts development of PH also warrants further evaluation.
